OnKure Therapeutics, Inc.
OKURNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $128.66M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.01$5.38
- Volume (live)
- -
- Avg. volume (3M)
- 368.58K
OnKure Therapeutics (OKUR) Stock Price & Financial Analysis
OnKure Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.28 - $2.59 |
|---|---|
| 52-Week High | $5.38 |
| 52-Week Low | $2.01 |
| Open | $2.30 |
| Volume (last close) | 243.67K |
| Average Volume (3M) | 368.58K |
| 50-Day MA | $3.14 |
|---|---|
| 200-Day MA | $3.63 |
| 1-Year Change | −13.42% |
| Market Cap | 128.66M |
|---|---|
| Shares Outstanding | 49.87M |
| Price to Book (P/B) | 0.75 |
| EV/EBITDA | 0.61 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
OnKure Therapeutics at a Glance
As of the Oct 22, 2026 close, OnKure Therapeutics (OKUR) has a market capitalization of $128.66M.
As of its latest reported balance sheet, it holds $166.50M in cash and securities against $926.00K of debt, a net cash position of $165.58M.
OnKure Therapeutics does not currently pay a dividend.
The share price is down 13.4% over the past year. At $2.58 (the Oct 22, 2026 close) it sits within its 52-week range of $2.01 to $5.38, below its 200-day moving average of $3.63.
Based on 3 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $15.00, 481.4% above the Oct 22, 2026 close.
Frequently Asked Questions About OnKure Therapeutics
What is the current stock price for OKUR?
As of the Oct 22, 2026 close, OKUR stock trades at $2.58. The 52-week range is $2.01–$5.38, with a day range of $2.28–$2.59.
What is the P/E ratio for OKUR?
The P/E ratio (Price-to-Earnings) for OKUR is shown in the Key Statistics section. This valuation metric helps compare OnKure Therapeutics, Inc. to industry peers.
Does OKUR pay dividends?
OnKure Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for OKUR?
Based on ratings from 3 professional analysts over the last 90 days, the consensus for OKUR is Buy. The average 12-month price target is $15.00, a 481.4% upside from the Oct 22, 2026 close of $2.58.
What is the market cap of OKUR?
As of the Oct 22, 2026 close, OnKure Therapeutics's market capitalization is $128.7M, classifying it as a micro-cap company. OnKure Therapeutics operates in the Healthcare sector within the Biotechnology industry.